Literature DB >> 30681515

Comparative Functional Outcomes After Corneal Crosslinking Using Standard, Accelerated, and Accelerated With Higher Total Fluence Protocols.

Paul Z Lang1, Nikki L Hafezi2, Sumitra S Khandelwal3, Emilio A Torres-Netto2,4,5, Farhad Hafezi1,2,4,6,7, J Bradley Randleman1,7.   

Abstract

PURPOSE: To compare the relative 12-month corneal crosslinking (CXL) functional outcomes using standard protocol and accelerated protocols in patients with progressive keratoconus.
METHODS: CXL was performed using 3 epithelium-off protocols: standard [3 mW/cm for 30 minutes, 5.4 J/cm (S3/30-CXL)], accelerated with equivalent total irradiance [9 mW/cm for 10 minutes, 5.4 J/cm (A9/10-CXL)], and accelerated with increased total irradiance [30 mW/cm for 4 minutes, 7.2 J/cm (A30/4-CXL)]. Efficacy measurements were evaluated 12 months after treatment with Scheimpflug imaging (Pentacam HR) and included change in maximum keratometry (K Max), corrected distance visual acuity (CDVA), other keratometric variables, pachymetry, keratoconus indices, astigmatism, asphericity, manifest refraction, and higher order aberrations.
RESULTS: Ninety-three eyes (67 patients) were evaluated: 35 eyes (26 patients) with S3/30-CXL, 29 eyes (19 patients) with A9/10-CXL, and 29 eyes (22 patients) with A30/4-CXL. Mean [INCREMENT]K Max was -1.53 ± 2.1 diopter (D) for S3/30-CXL, -0.71 ± 1.3 D for A9/10-CXL, and -0.70 ± 2.3 D for A30/4-CXL (P = 0.37). Mean [INCREMENT]CDVA(logMAR) was -0.18 ± 0.2 for S3/30-CXL, -0.13 ± 0.2 for A9/10-CXL, and -0.18 ± 0.2 for A30/4-CXL (P = 0.79). [INCREMENT]K Mean (r = -0.29 to -0.46), anterior asphericity (r = -0.34 to -0.40), and central keratoconus index (r = -0.18 to -0.38) best correlated with [INCREMENT]CDVA. S3/30-CXL had greater changes in index of surface variance, index of vertical asymmetry, keratoconus index, and regularization index compared to A9/10-CXL and A30/4-CXL. There were no other differences between protocols.
CONCLUSIONS: All 3 protocols showed improvements in K Max, CDVA, and other variables, with similar functional outcomes for each despite greater change in keratoconus indices after S3/30-CXL. Correlations between change in measured variables and CDVA were poor overall; however, K Mean, central keratoconus index, and anterior asphericity were better correlated with CDVA than K Max.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30681515     DOI: 10.1097/ICO.0000000000001878

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  11 in total

1.  Complications of accelerated corneal collagen cross-linking: review of 2025 eyes.

Authors:  Semih Çakmak; Mehmet Emin Sucu; Yusuf Yildirim; Burcin Kepez Yildiz; Ahmet Kirgiz; Damla Leman Bektaşoğlu; Ahmet Demirok
Journal:  Int Ophthalmol       Date:  2020-07-26       Impact factor: 2.031

Review 2.  [Treatment indications for corneal crosslinking and clinical results of new corneal crosslinking techniques].

Authors:  Klara Borgardts; Johannes Menzel-Severing; Gerd Geerling; Theo G Seiler
Journal:  Ophthalmologe       Date:  2022-02-11       Impact factor: 1.059

3.  Efficacy of Standard and Accelerated (10 Minutes) Corneal Crosslinking in Keratoconus Stabilization.

Authors:  Ricardo Alexandre Stock; Gustavo Brustollin; Rafael André Mergener; Elcio Luiz Bonamigo
Journal:  Clin Ophthalmol       Date:  2020-06-24

4.  Visual and Refractive Long-Term Outcomes Following Standard Cross-Linking in Progressive Keratoconus Management.

Authors:  Mohammed Iqbal; Ahmed Elmassry; Amani E Badawi; Hesham M Gharieb; Omar M Said
Journal:  Clin Ophthalmol       Date:  2019-12-12

5.  Comparison of waveform-derived corneal stiffness and stress-strain extensometry-derived corneal stiffness using different cross-linking irradiances: an experimental study with air-puff applanation of ex vivo porcine eyes.

Authors:  Robert Herber; Mathew Francis; Eberhard Spoerl; Lutz E Pillunat; Frederik Raiskup; Abhijit Sinha Roy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-06-17       Impact factor: 3.117

6.  Long term results of accelerated 9 mW corneal crosslinking for early progressive keratoconus: the Siena Eye-Cross Study 2.

Authors:  Cosimo Mazzotta; Frederik Raiskup; Farhad Hafezi; Emilio A Torres-Netto; Ashraf Armia Balamoun; Giuseppe Giannaccare; Simone Alex Bagaglia
Journal:  Eye Vis (Lond)       Date:  2021-05-01

7.  PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial.

Authors:  Farhad Hafezi; Mohammed Hosny; Rohit Shetty; Boris Knyazer; Shihao Chen; Qinmei Wang; Hassan Hashemi; Emilio A Torres-Netto
Journal:  Eye Vis (Lond)       Date:  2022-01-07

8.  Long-Term Follow-Up of Accelerated Transepithelial Corneal Crosslinking for Post-LASIK Ectasia: A Pilot Prospective Observational Study.

Authors:  Mi Tian; Xiaoyu Zhang; Weijun Jian; Ling Sun; Yang Shen; Xingtao Zhou
Journal:  Front Bioeng Biotechnol       Date:  2021-12-22

9.  Accelerated versus conventional corneal collagen crosslinking: Short-term clinical outcomes in stabilizing keratoconus.

Authors:  Walaa Aldairi; Reham AlQahtani; Salem Alzaid; Ahmed Mousa; Rajiv Khandekar; Samar A Al-Swailem
Journal:  Saudi J Ophthalmol       Date:  2022-07-11

10.  Factors influencing harmonized health data collection, sharing and linkage in Denmark and Switzerland: A systematic review.

Authors:  Lester Darryl Geneviève; Andrea Martani; Maria Christina Mallet; Tenzin Wangmo; Bernice Simone Elger
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.